Profil
Eric Zhang is the founder of AKSO Biopharmaceutical, Inc. Prior to founding AKSO Biopharmaceutical, he worked as a Director at Versartis, Inc. He also worked as a Director at Aravive Biologics, Inc. from 2016 to 2018.
From 2018 to 2023, he served as an Independent Director at Aravive, Inc. Mr. Zhang received his undergraduate degree from Queen's University.
Postes actifs de Eric Zhang
| Sociétés | Poste | Début |
|---|---|---|
AKSO Biopharmaceutical, Inc. | Directeur Général | - |
Anciens postes connus de Eric Zhang
| Sociétés | Poste | Fin |
|---|---|---|
| ARAVIVE, INC. | Directeur/Membre du Conseil | 02/10/2023 |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry | Directeur/Membre du Conseil | 01/10/2018 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Directeur/Membre du Conseil | - |
Formation de Eric Zhang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry | Health Technology |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
AKSO Biopharmaceutical, Inc. |
















